LYMPHOCYTES T MODIFIES POUR LE TRAITEMENT DU CANCER
- 专利权人:
- TCR2 THERAPEUTICS INC.
- 发明人:
- GETTS, DANIEL,PATEL, EKTA,BAEUERLE, PATRICK,HOFMEISTER, ROBERT
- 申请号：
- CA3047999
- 公开号：
- CA3047999A1
- 申请日:
- 2017.12.21
- 申请国别(地区):
- CA
- 年份:
- 2018
- 代理人:
- 摘要：
- Provided herein are T-cell receptor (TCR) fusion proteins (TFPs), T cells engineered to express one or more TFPs, and methods of use thereof for the treatment of diseases, including cancer.
- 来源网站：
- 中国工程科技知识中心
